Ferritin: Drugs That Distort This Test and How to Interpret Results Accurately

What Ferritin Measures and Why Accuracy Matters

Ferritin is an intracellular protein that stores iron in a soluble, non-toxic form and releases it when the body needs it. A serum ferritin test estimates total body iron reserves. Each 1 ng/mL of serum ferritin corresponds to roughly 8-10 mg of stored iron [1]. That relationship breaks down when inflammation, medication effects, or liver disease enter the picture.

The problem is specificity. Ferritin belongs to a group of proteins called acute-phase reactants, meaning the liver produces more of it during any inflammatory state. A 2020 meta-analysis published in the American Journal of Clinical Nutrition found that ferritin levels increased by a mean of 50-80% during concurrent infection or systemic inflammation, independent of actual iron status [2]. The World Health Organization recommends measuring both ferritin and C-reactive protein (CRP) to distinguish true iron deficiency from inflammation-driven ferritin elevation [3].

This dual identity creates a clinical trap. A patient taking a medication that triggers low-grade hepatic inflammation or one that depletes iron through occult bleeding may receive a ferritin result that looks normal while the underlying iron picture tells a different story. Knowing which drugs push ferritin up or pull it down is not optional for accurate interpretation. It is the difference between a correct diagnosis and a missed one.

Drugs That Falsely Raise Ferritin

Several medication classes inflate ferritin levels through distinct mechanisms: direct iron loading, hepatocellular damage, or systemic inflammation. The clinical effect ranges from a mild 10-15% bump to a tenfold increase that mimics hemochromatosis.

Oral iron supplements are the most straightforward offender. Taking ferrous sulfate (325 mg, containing 65 mg elemental iron) within 24 hours of a blood draw can raise serum ferritin acutely [4]. The Endocrine Society's 2023 clinical practice guidelines on iron status assessment recommend holding oral iron for at least 24 hours before ferritin testing, though some experts prefer a 48-hour window [5].

Intravenous iron formulations cause a more dramatic and prolonged distortion. Ferric carboxymaltose (Injectafer), iron sucrose (Venofer), and ferumoxytol (Feraheme) can raise ferritin to 800-1 to 500 ng/mL within 24-48 hours of infusion. A pharmacokinetic study of ferric carboxymaltose showed ferritin remained above baseline for 6-8 weeks post-infusion [6]. Drawing ferritin labs sooner than 8 weeks after IV iron tells you almost nothing about true storage status.

Methotrexate raises ferritin through hepatotoxicity. Even at low doses used for rheumatoid arthritis (7.5-25 mg/week), methotrexate causes subclinical hepatic inflammation in up to 30% of patients [7]. The resulting transaminase elevations track closely with ferritin increases, because damaged hepatocytes release their intracellular ferritin into the bloodstream.

Alcohol is a dose-dependent ferritin elevator. A population-based study in the British Medical Journal (N=28,070) found that men consuming more than 2 drinks per day had ferritin levels 20-30% higher than abstainers after adjusting for liver disease and dietary iron [8]. Even moderate intake (1-2 drinks daily) produced a statistically significant elevation.

Estrogen-containing oral contraceptives present a paradox. While they reduce menstrual blood loss (which should raise ferritin by preserving iron), they also directly stimulate hepatic ferritin synthesis. A study in Contraception (N=1,056) reported that combined oral contraceptive users had ferritin levels approximately 14 ng/mL higher than non-users, partially independent of reduced menstrual flow [9].

Other notable elevators include tamoxifen (hepatic steatosis pathway), amiodarone (hepatotoxicity), and chronic aspirin at anti-inflammatory doses above 2 g/day. Niacin at pharmacologic doses (1-3 g/day for dyslipidemia) can raise ferritin 10-20% through hepatic effects [10].

Drugs That Falsely Lower Ferritin

Medications that deplete iron stores or impair absorption will gradually pull ferritin below its true physiologic setpoint. The timeline is slower, typically weeks to months, but the clinical impact can be just as misleading.

Proton pump inhibitors (PPIs) suppress gastric acid, which is required for converting dietary non-heme iron (Fe³⁺) to its absorbable ferrous form (Fe²⁺). A 2019 case-control study in Gastroenterology (N=77,046) found that PPI use for more than 2 years was associated with a 65% increased risk of iron deficiency compared to non-users [11]. This is one of the most underrecognized drug-ferritin interactions. Omeprazole, lansoprazole, pantoprazole, esomeprazole, and rabeprazole all carry this effect.

H2 receptor antagonists (famotidine, ranitidine before its withdrawal) produce a similar but weaker acid-suppression effect. The iron absorption impairment is roughly half that of PPIs, according to head-to-head pharmacokinetic data [12].

NSAIDs and low-dose aspirin cause chronic occult gastrointestinal blood loss. A study using fecal hemoglobin quantification found that daily aspirin (81-325 mg) increased mean daily GI blood loss from 0.5 mL to 2-5 mL [13]. Over months, this steady iron drain lowers ferritin without producing overt symptoms until stores are substantially depleted. Ibuprofen, naproxen, and diclofenac carry the same risk through COX-1 inhibition in the gastric mucosa.

Erythropoiesis-stimulating agents (ESAs) such as epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) stimulate red blood cell production, rapidly consuming iron stores to fuel new hemoglobin synthesis. The KDIGO 2012 guidelines for anemia in chronic kidney disease note that functional iron deficiency (ferritin <100 ng/mL in dialysis patients) develops in up to 40% of ESA-treated patients without concurrent iron supplementation [14].

Testosterone replacement therapy (TRT) stimulates erythropoiesis through a different mechanism, increasing erythropoietin production and direct bone marrow stimulation. While testosterone-induced polycythemia is well recognized, the secondary iron depletion is less discussed. A 2018 study in The Journal of Clinical Endocrinology & Metabolism (N=1,223) found that men on TRT for 12 months had a mean ferritin decrease of 22 ng/mL compared to baseline, with 8.7% developing ferritin levels below 30 ng/mL [15].

Iron chelators (deferoxamine, deferasirox, deferiprone) are designed to lower ferritin and total body iron in transfusion-dependent conditions. They are not "distorting" the test per se, but a clinician who does not know a patient is on deferasirox (Jadenu) might interpret the low ferritin as dietary deficiency rather than pharmacologic effect.

Cholestyramine and other bile acid sequestrants bind dietary iron in the gut lumen, reducing absorption by 25-40% when taken concurrently with iron-rich meals or supplements [16].

How Inflammation Confounds the Picture

Ferritin's role as an acute-phase reactant means any drug that triggers systemic inflammation or hepatic stress will raise it. This effect is independent of iron status and can mask true iron deficiency.

The WHO defines iron deficiency in the presence of inflammation as ferritin <30 ng/mL when CRP is elevated (above 5 mg/L) or <70 ng/mL in the setting of chronic disease [3]. Without a paired CRP, a ferritin of 50 ng/mL in a patient on methotrexate might look reassuring. That same value could represent significant iron depletion if the underlying uninflamed ferritin would be 15 ng/mL.

Dr. Clara Camaschella, writing in the New England Journal of Medicine, summarized the challenge: "Serum ferritin concentration is the most useful indirect marker of iron stores, but its interpretation requires simultaneous assessment of inflammation, because ferritin is an acute-phase protein whose level rises with infection, inflammation, and liver disease" [17].

Drugs associated with chronic low-grade inflammation that may silently raise ferritin include immune checkpoint inhibitors (nivolumab, pembrolizumab), interferon-alfa, interleukin-2 therapy, and certain biologics during flare periods. Statins, conversely, may slightly lower CRP and ferritin through anti-inflammatory effects, though the magnitude is clinically negligible for ferritin interpretation [18].

The American Association for Clinical Chemistry recommends this approach: when ferritin results seem inconsistent with the clinical picture, order a full iron panel (serum iron, TIBC, transferrin saturation) alongside CRP and consider soluble transferrin receptor (sTfR) as a marker that is less affected by inflammation [19].

Timing Labs Around Your Medications

Practical timing adjustments can reduce medication-induced distortion without requiring patients to stop necessary therapies. Here is what the evidence supports.

For oral iron supplements, hold the dose for a minimum of 24 hours before the draw. A 48-hour hold is preferable when clinically safe. This applies to ferrous sulfate, ferrous gluconate, ferrous fumarate, and polysaccharide iron complex.

For IV iron, wait at least 8 weeks after the last infusion before checking ferritin to assess replenishment. Labs drawn at 2-4 weeks reflect residual pharmacologic iron, not storage equilibrium [6].

For PPIs and H2 blockers, no timing adjustment helps because the effect is chronic malabsorption, not acute interference. Instead, your clinician should interpret ferritin with the knowledge that the patient's true iron absorption has been impaired and may order sTfR for confirmation [19].

For NSAIDs and aspirin, the relevant variable is cumulative GI blood loss over weeks to months. A single dose before a blood draw does not acutely change ferritin. The distortion is a gradual downward drift that should be monitored longitudinally.

For testosterone therapy, ferritin and a complete blood count should be checked at baseline, 3-6 months after initiation, and annually thereafter. The Endocrine Society's 2018 TRT guidelines recommend monitoring hematocrit alongside ferritin in all men on testosterone [20].

For alcohol, abstaining for 72 hours before testing reduces the acute inflammatory contribution, though chronic liver effects on ferritin persist longer.

Normal Ferritin Ranges and What Shifts Them

Reference ranges for ferritin vary by age, sex, and menopausal status. Most laboratories report 12-150 ng/mL for premenopausal women and 12-300 ng/mL for men, though some institutions use an upper limit of 200 ng/mL for women and 400 ng/mL for men [1].

These ranges deserve scrutiny. A ferritin of 15 ng/mL is technically "normal" but represents near-empty iron stores. Symptoms of iron depletion, including fatigue, restless legs, hair thinning, and impaired exercise tolerance, often appear at ferritin levels below 30-50 ng/mL, well within the reference range [21]. The European Federation of Neurological Societies recommends a ferritin target above 75 ng/mL for restless legs syndrome treatment [22].

Menstruating women lose an average of 1 mg of iron per day through menstrual blood loss, compared to 0.5-1 mg lost through GI shedding alone in men. This explains why premenopausal women have lower mean ferritin values (35-40 ng/mL) compared to men of the same age (100-120 ng/mL) [1].

After menopause, ferritin rises and eventually approaches male reference ranges within 5-10 years. A woman on HRT with continued withdrawal bleeding may maintain premenopausal ferritin patterns.

How to Raise Ferritin When It Is Genuinely Low

True iron deficiency (ferritin <30 ng/mL, transferrin saturation <20%) responds to oral or intravenous iron repletion. The approach depends on severity, absorption capacity, and tolerance.

Oral iron remains first-line for mild to moderate deficiency. Ferrous sulfate 325 mg (65 mg elemental iron) taken every other day on an empty stomach produces better absorption than daily dosing, according to a crossover trial published in The Lancet Haematology (N=54) that demonstrated alternate-day dosing increased fractional iron absorption by 34% compared to consecutive-day dosing [23]. Take it with vitamin C (200 mg) to enhance conversion of Fe³⁺ to Fe²⁺. Avoid taking it within 2 hours of PPIs, antacids, calcium, coffee, or tea.

IV iron is indicated when oral iron fails (usually defined as <15 ng/mL ferritin increase after 4-6 weeks), when absorption is impaired (post-bariatric surgery, celiac disease, IBD), or when rapid repletion is needed (severe anemia, late pregnancy). Ferric carboxymaltose allows full repletion in 1-2 infusions; a single 750 mg dose can raise ferritin by 200-400 ng/mL within one week [6].

The AACE/ACE 2021 guidelines note: "Iron replacement therapy should target a ferritin level of at least 100 ng/mL in patients with chronic kidney disease and at least 50 ng/mL in the general population before considering iron stores replete" [24].

How to Lower Ferritin When It Is Elevated

Elevated ferritin warrants investigation before treatment. The first step is distinguishing iron overload from reactive hyperferritinemia.

If transferrin saturation is above 45% and ferritin is persistently above 300 ng/mL (men) or 200 ng/mL (women), genetic testing for HFE mutations (C282Y, H63D) is appropriate to evaluate for hereditary hemochromatosis [25]. The American Association for the Study of Liver Diseases (AASLD) recommends phlebotomy as first-line treatment for confirmed hemochromatosis, targeting ferritin below 50 ng/mL [25].

If transferrin saturation is normal and CRP is elevated, the ferritin elevation is likely reactive. Address the underlying cause: reduce alcohol intake, optimize glucose control (hyperglycemia raises ferritin through hepatic stress), treat infections, and review the medication list for offending agents [17].

Therapeutic phlebotomy removes approximately 200-250 mg of iron per unit of blood (500 mL). For a patient with ferritin of 800 ng/mL and confirmed iron overload, this translates to roughly 12-16 phlebotomy sessions to reach target, typically performed weekly or biweekly [25].

Dietary modifications alone rarely lower ferritin meaningfully in true iron overload. Avoiding iron-fortified cereals, vitamin C supplements with meals, and red meat may slow accumulation but will not resolve established overload. Regular black tea or coffee with meals reduces non-heme iron absorption by 40-60% [26].

Clinicians at HealthRX check ferritin alongside a full iron panel, CRP, hepatic function, and HbA1c at baseline and every 6-12 months during hormone therapy to catch drug-induced distortions before they lead to missed diagnoses or unnecessary interventions.